Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Communications Medicine, 2026

Divergent inflammatory and neurology-related protein levels in long COVID following primary and breakthrough SARS-CoV-2 infections

Bansal A., Olechnowicz S., Kiernan-Walker N. et al.

eBioMedicine, 2026

Blood-based biomarker discovery for early pregnancy loss using integrative multi-omics strategies

Shi Y., Yang Y., Guo X. et al.

Nature Medicine, 2026

Plasma proteomic signature of the human menstrual cycle

Riishede I., Rode L., Lundegaard P. et al.

Cancer Pathogenesis and Therapy, 2026

Genetically predicted inflammatory mediators link mitochondrial function to breast cancer risk: A Mendelian randomization study

Ran L., Feng J., Chen J. et al.

Archives of Gerontology and Geriatrics, 2026

Hepatic dysfunction and long-term risk of neurodegenerative diseases: A UK Biobank-based analysis

Su W., Duan Q., He S. et al.

Diabetic Medicine, 2026

A multi‐omics risk score enables early and personalized screening for type 2 diabetes: A population‐based cohort study

Bu F., Fang C., Zheng X. et al.

eBioMedicine, 2026

Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap

Stinson S., Shadrin A., Rahman Z. et al.

Lipids in Health and Disease, 2026

Associations of plasma level of soluble LDL receptor with cardiovascular events and mortality in a large prospective cohort study

Kim S., Jun H., Jo G. et al.

Journal for ImmunoTherapy of Cancer, 2026

Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Sato Y., Kodama T., Maesaka K. et al.

Journal of the American Society of Nephrology, 2026

RARRES1 Promotes Tubular Fibrosis via the KHDRBS1/Src/p-STAT3 Axis

Ye L., Jiang Z., Wu Y. et al.

ESC Heart Failure, 2026

Plasma protein profiles in different heart failure phenotypes

Lind L., Delgado-Velandia M.

Journal of Periodontal Research, 2026

Proteomic Characterization of Grade II Furcation Defects: A Discovery‐Phase Study

Chatzopoulos G., Sakellari D., Kaklamanos E. et al.

Hypertension, 2026

Integrative Proteomic Profiling of Blood Pressure and Hypertension

Aggarwal M., Joehanes R., Huan T. et al.

Translational Psychiatry, 2026

Astrocyte-related proteins mediate the association of YWHAG with Alzheimer’s pathology and enhance its diagnostic value

Zhang Z., Huang P., Yang Y. et al.

Lipids in Health and Disease, 2026

Significant correlations between blood lipids, cytokines, and C-reactive protein in healthy humans

Larsson A., Eriksson L., Eriksson M.

Journal of Investigative Dermatology, 2026

Serum proteomics analysis identifies differentially expressed proteins in early-stage mycosis fungoides versus healthy controls

Sacknovitz Y., Zhou M., Kent J. et al.

Clinical Rheumatology, 2026

Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjögren’s syndrome to total risk non-Hodgkin lymphoma

Wang H., Yan H., Yang M. et al.

Cardiovascular Research, 2026

miR-146a-5p mediates atherogenic signalling from immune to vascular cells

Climent M., Zani S., Salvarani N. et al.

HemaSphere, 2026

Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients

Diorio C., Myers R., Li Y. et al.

Metabolism, 2026

When the proteome meets the metabolome observational and Mendelian randomization analyses

Zheng R., Delgado-Velandia M., Ärnlöv J. et al.

4626 publications